end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccountsPayableTradeCurrentAndNoncurrent,AccountsReceivableGrossCurrent,AccountsReceivableNetCurrent,AccruedEmployeeBenefitsCurrent,AccruedLiabilitiesCurrent,AccruedSalariesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AdditionalPaidInCapital,AdditionalPaidInCapitalCommonStock,AdjustmentOfWarrantsGrantedForServices,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AdjustmentsToAdditionalPaidInCapitalWarrantIssued,AllocatedShareBasedCompensationExpense,AmortizationOfDebtDiscountPremium,AmortizationOfFinancingCosts,AmortizationOfIntangibleAssets,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,AreaOfLand,AssetImpairmentCharges,Assets,AssetsCurrent,AssetsNoncurrent,AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent,AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent,BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued,BusinessAcquisitionsProFormaNetIncomeLoss,Cash,CashAcquiredFromAcquisition,CashAndCashEquivalentsAtCarryingValue,CashAndCashEquivalentsPeriodIncreaseDecrease,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CashFDICInsuredAmount,ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights,ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights,ClassOfWarrantOrRightOutstanding,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockParOrStatedValuePerShare,CommonStockShareSubscribedButUnissuedSubscriptionsReceivable,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockSharesSubscriptions,CommonStockValue,ConvertiblePreferredStockSharesIssuedUponConversion,CostOfGoodsSoldDepreciationAndAmortization,CostOfRevenue,CurrentFederalTaxExpenseBenefit,CurrentStateAndLocalTaxExpenseBenefit,DebtInstrumentDecreaseForgiveness,DebtInstrumentInterestRateStatedPercentage,DeferredFederalIncomeTaxExpenseBenefit,DeferredIncomeTaxExpenseBenefit,DeferredRentCreditCurrent,DeferredRentCreditNoncurrent,DeferredStateAndLocalIncomeTaxExpenseBenefit,DeferredTaxAssetsGross,DeferredTaxAssetsLiabilitiesNet,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOther,DeferredTaxAssetsTaxCreditCarryforwardsResearch,DeferredTaxAssetsTaxDeferredExpense,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses,DeferredTaxAssetsValuationAllowance,DepositsAssetsNoncurrent,Depreciation,DepreciationAndAmortizationDiscontinuedOperations,DepreciationDepletionAndAmortization,DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure,DerivativeLiabilitiesCurrent,DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax,DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax,DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax,DueToOfficersOrStockholdersCurrent,DueToOfficersOrStockholdersCurrentAndNoncurrent,EarningsPerShareBasic,EarningsPerShareBasicAndDiluted,EarningsPerShareDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate,EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential,EffectiveIncomeTaxRateReconciliationOtherAdjustments,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationTaxCredits,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,EquityIssuancePerShareAmount,EquityMethodInvestmentOwnershipPercentage,EscrowDeposit,FairValueAdjustmentOfWarrants,FairValueInputsDiscountRate,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue,FairValueOfAssetsAcquired,FiniteLivedIntangibleAssetsAccumulatedAmortization,FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive,FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths,FiniteLivedIntangibleAssetsAmortizationExpenseYearFive,FiniteLivedIntangibleAssetsAmortizationExpenseYearFour,FiniteLivedIntangibleAssetsAmortizationExpenseYearThree,FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo,FiniteLivedIntangibleAssetsGross,FiniteLivedIntangibleAssetsNet,GainLossOnDispositionOfAssets1,GainLossOnSaleOfBusiness,GainLossOnSaleOfLeasedAssetsNetOperatingLeases,GainLossOnSalesOfAssetsAndAssetImpairmentCharges,GainsLossesOnExtinguishmentOfDebt,GeneralAndAdministrativeExpense,Goodwill,GrantsReceivable,GrossProfit,ImpairmentOfIntangibleAssetsFinitelived,ImpairmentOfInvestments,ImpairmentOfLongLivedAssetsHeldForUse,IncomeLossFromContinuingOperations,IncomeLossFromContinuingOperationsPerBasicAndDilutedShare,IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity,IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare,IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority,IncomeTaxExaminationPenaltiesAndInterestExpense,IncomeTaxExpenseBenefit,IncomeTaxExpenseBenefitContinuingOperations,IncomeTaxesPaid,IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccountsReceivable,IncreaseDecreaseInAccruedLiabilities,IncreaseDecreaseInCashCollateralForLoanedSecurities,IncreaseDecreaseInDeferredLiabilities,IncreaseDecreaseInDeferredRentReceivables,IncreaseDecreaseInDepositOtherAssets,IncreaseDecreaseInDeposits,IncreaseDecreaseInInventories,IncreaseDecreaseInOtherNoncurrentAssets,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,IncreaseDecreaseInSecurityDeposits,IncrementalCommonSharesAttributableToCallOptionsAndWarrants,IncrementalCommonSharesAttributableToConversionOfPreferredStock,IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit,IndefiniteLivedLicenseAgreements,IntangibleAssetsNetExcludingGoodwill,InterestExpense,InterestPaid,InterestPaidNet,InventoryAdjustments,InventoryFinishedGoods,InventoryGross,InventoryNet,InventoryRawMaterials,InventoryValuationReserves,InventoryWriteDown,InvestmentIncomeInterest,InvestmentsFairValueDisclosure,IssuanceOfStockAndWarrantsForServicesOrClaims,LeaseAndRentalExpense,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent,LongTermInvestments,LongTermNotesPayable,MarketingAndAdvertisingExpense,MinorityInterest,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,NetCashProvidedByUsedInOperatingActivities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,NetIncomeLoss,NetIncomeLossAttributableToNoncontrollingInterest,NetIncomeLossAvailableToCommonStockholdersBasic,NoncashOrPartNoncashAcquisitionAccountsReceivableAcquired1,NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1,NoncashOrPartNoncashAcquisitionInventoryAcquired1,NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1,NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1,NoncashOrPartNoncashAcquisitionPayablesAssumed1,NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1,NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1,NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1,NonoperatingIncomeExpense,NotesIssued1,NotesPayableCurrent,NumberOfOperatingSegments,NumberOfOperatingSegments,NumberOfOperatingSegments,NumberOfReportableSegments,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeaseRightOfUseAsset,OperatingLeasesFutureMinimumPaymentsDue,OperatingLeasesFutureMinimumPaymentsDueCurrent,OperatingLeasesFutureMinimumPaymentsDueInFourYears,OperatingLeasesFutureMinimumPaymentsDueInThreeYears,OperatingLeasesFutureMinimumPaymentsDueInTwoYears,OperatingLeasesRentExpenseNet,OperatingLeaseWeightedAverageDiscountRatePercent,OperatingLossCarryforwards,OtherAccruedLiabilitiesCurrent,OtherAssets,OtherAssetsNoncurrent,OtherNonoperatingIncomeExpense,OtherRestrictedAssetsCurrent,PaymentsForRent,PaymentsOfDebtIssuanceCosts,PaymentsOfFinancingCosts,PaymentsOfStockIssuanceCosts,PaymentsToAcquireInProcessResearchAndDevelopment,PaymentsToAcquirePropertyPlantAndEquipment,PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged,PreferredStockDividendsAndOtherAdjustments,PreferredStockDividendsIncomeStatementImpact,PreferredStockSharesSubscribedButUnissuedSubscriptionsReceivable,PreferredStockSharesSubscribedButUnissuedValue,PreferredStockValueOutstanding,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromDivestitureOfBusinesses,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfConvertiblePreferredStock,ProceedsFromIssuanceOfLongTermDebt,ProceedsFromIssuanceOfPreferredStockAndPreferenceStock,ProceedsFromIssuanceOrSaleOfEquity,ProceedsFromLongTermLinesOfCredit,ProceedsFromNotesPayable,ProceedsFromOtherDebt,ProceedsFromRelatedPartyDebt,ProceedsFromRepaymentsOfNotesPayable,ProceedsFromRepaymentsOfRelatedPartyDebt,ProceedsFromSaleOfInterestInCorporateUnit,ProceedsFromSaleOfProductiveAssets,ProceedsFromWarrantExercises,ProfitLoss,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ProvisionForDoubtfulAccounts,RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty,RepaymentsOfLongTermDebt,RepaymentsOfNotesPayable,RepaymentsOfRelatedPartyDebt,ResearchAndDevelopmentExpense,RestrictedCashAndCashEquivalents,RestrictedCashAndCashEquivalentsAtCarryingValue,RestrictedCashAndCashEquivalentsNoncurrent,RestrictedInvestmentsCurrent,RetainedEarningsAccumulatedDeficit,RevenueFromGrants,RevenueRecognitionSalesReturnsReserveForSalesReturns,Revenues,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,SalesRevenueGoodsNet,SecurityDeposit,SegmentReportingInformationRevenue,SellingGeneralAndAdministrativeExpense,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue,SharePrice,SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit,StockholdersEquity,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares,StockIssued1,StockIssuedDuringPeriodSharesIssuedForCash,StockIssuedDuringPeriodSharesIssuedForServices,StockIssuedDuringPeriodSharesNewIssues,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueAcquisitions,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueConversionOfUnits,StockIssuedDuringPeriodValueIssuedForCash,StockIssuedDuringPeriodValueIssuedForServices,StockIssuedDuringPeriodValueNewIssues,StraightLineRent,TechnologyServicesCosts,TreasuryStockValue,UnrealizedGainLossOnDerivatives,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense,UnrecognizedTaxBenefitsResultingInNetOperatingLossCarryforward,ValuationAllowanceDeferredTaxAssetChangeInAmount,WarrantsNotSettleableInCashFairValueDisclosure,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,WeightedAverageNumberOfSharesOutstandingBasic
2009-12-31,2010-03-16,10-K,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3363665.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,31905.0,251901.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-2154575.0,,,,,,,,,,,,,,,,,,,,,,,,,
2010-06-30,2010-08-09,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9925704.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-0.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1358870.0,,,,,,,-690324.0,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,743.0,,,,,,,,,,12878.0,,,,,,,,,,,,,,,,,,,,,,,-690324.0,,,,,,,,,,,,,,,,,,,1972069.0,-1972069.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,613199.0,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1269610.0,,,,,,,,
2010-09-30,2010-11-09,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7700648.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-0.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1083066.0,,,,,,,-3448731.0,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,247.0,,,,,,,,,,9296.0,,,,,,,,,,,,,,,,,,,,,,,-3448731.0,,,,,,,,,,,,,,,,,,,1821080.0,-1821080.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,738014.0,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-1636700.0,,,,,,,,
2010-12-31,2011-04-15,10-K,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,597868.0,,,,,748113.0,,,,88381852.0,,390268.0,-901139.0,,0.0,0.0,0.0,,,,9512075.0,7912189.0,,,,,,,0.0,6644054.0,3280389.0,,,,,,3339675.0,,0.0001,,200000000.0,83097967.0,83097967.0,,8310.0,,,,,,,,,,,164782.0,,,,,,,,,,,,,,,169005.0,,,,573073.0,,0.0,0.0,,,,-0.06,,,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,,,0.0,,,4700404.0,,,,,,,-4736291.0,,0.0,,,,,,2400.0,,-1702918.0,-115138.0,411656.0,0.0,,25332.0,,3630.0,0.0,,2751.0,,,,,,,2999.0,2999.0,,,,,0.0,,,0.0,33687.0,,0.0,,,,,,,2083836.0,9512075.0,1919054.0,,0.0,,,,10811563.0,,-117408.0,,-7413766.0,,-4736291.0,,,,,,,,,,,,,500000.0,,,,,,7014243.0,-6769764.0,,,,,,,,,,,,,,,176308.0,,,,,,,,52408.0,,,,,,,43135.0,0.0,10811563.0,,,,,0.0,,0.0,,,,0.0,,0.0,,,234942.0,0.0,,0.0,,,2313839.0,,1225000.0,200000.0,,-80961923.0,244479.0,,,,,,,,390268.0,,,,,,,,,,3605000.0,1.67,,,,,,,,,7428239.0,,,1000000.0,,,,,,,,,,10393260.0,,,,1528913.0,,,,,,,,
2011-03-31,2011-05-16,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,,,,,,,,,,,,,0.0,,0.0,0.0,0.0,,,,,,,,,,,,0.0,4934299.0,-1709755.0,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,26635.0,,,,,,0.0,0.0,,,,-0.02,,,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,,,0.0,,,1287885.0,,,0.0,,,,-1688640.0,,,,,,,,0.0,,-96208.0,0.0,11063.0,100000.0,,7591.0,,0.0,0.0,,10732.0,,,,,,,2613.0,1431.0,,,,,,,,0.0,5262.0,,0.0,,,,,,,,,,,,,,,100000.0,,-1358.0,,-1808397.0,,-1688640.0,,,,,,,,,,,,,0.0,,,,,,1779459.0,-1779459.0,,,,,,,,,,,,,,,,,,,,,,0.0,1358.0,,,,,,,,0.0,0.0,,,,,0.0,,0.0,,,,0.0,,0.0,,,,,,0.0,,,491574.0,,,,,,0.0,,0.0,,0.0,,,,22519.0,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,,,,,88170.0,,,,,,,,
2011-06-30,2011-08-15,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,632066.0,,,,,759979.0,,,,88463381.0,,,,59009.0,,,,,,,5866601.0,4554302.0,,,,,,,,3182919.0,,,,,,,,,0.0001,,200000000.0,83097967.0,83097967.0,,8310.0,,,0.0,,,,,,,,144232.0,,,,,,,,,,,,,,,,,,,272502.0,0.0,,0.0,,,,-0.02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1173536.0,,,0.0,,,,-1763306.0,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,1449.0,,,,,,,,,,3136.0,,,,,,,,,1808779.0,5866601.0,1664547.0,,,,,,,,,,,,-1763306.0,,,,,,,,,,,,,,,,,,,1977394.0,-1977394.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,146383.0,,,,,,,,,,,,,,,,,,183718.0,,,,,,803858.0,,1225000.0,100000.0,,-84413869.0,0.0,,0.0,,0.0,,,1173536.0,,,,,,,,,,,,,,,,,,,,,4057822.0,,,,,,,,,,,,,,,,,212401.0,,,,,,,83097967.0,
2011-09-30,2011-11-14,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,446738.0,,,,,749511.0,,,,88516536.0,,,,53155.0,,,,,,,3953089.0,2595220.0,,,,,,,,2258072.0,,,,,,,,,0.0001,,200000000.0,83097967.0,83097967.0,,8310.0,,,0.0,,,,,,,,131272.0,,,,,,,,,,,,,,,,,,,114874.0,0.0,,0.0,,,,-0.02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1180199.0,,,0.0,,,,-1600283.0,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,353.0,,,,,,,,,,1622.0,,,,,,,,,1442395.0,3953089.0,1311123.0,,,,,,,,,,,,-1600283.0,,,,,,,,,,,,,,,,,,,1759180.0,-1759180.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,237148.0,0.0,,,,,,,,,,,,,,,,,161107.0,,,,,,578981.0,,100000.0,100000.0,,-86014152.0,0.0,,0.0,,0.0,,,1180199.0,,,,,,,,,,,,,,,,,,,,,2510694.0,,,,,,,,,,,,,,,,,157628.0,,0.0,,,,,83097967.0,
2011-12-31,2012-03-30,10-K,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,749586.0,,0.0,0.0,339125.0,464894.0,,1214240.0,,94167335.0,,181229.0,0.0,181229.0,0.0,0.0,0.0,,,,7503229.0,5373613.0,,,,,,,0.0,4721279.0,-1922775.0,,,,,,2137650.0,,0.0001,,200000000.0,96585834.0,96585834.0,,8610.0,,103769.0,0.0,,,,,-880785.0,,,118313.0,-151143.0,32722622.0,,,31804793.0,9998.0,,86004.0,742392.0,,47129.0,,32722622.0,,103769.0,,,85506.0,85506.0,0.0,0.0,0.0,,,,-0.08,,0.0,-0.34,0.145,,,,-0.058,,,,,,,,,,,0.0,,,,,,,,,,,,0.0,,,4824659.0,0.0,0.0,0.0,,,0.0,-7129092.0,,0.0,,,,,-1031928.0,1600.0,1031928.0,151718.0,0.0,-283219.0,100000.0,,46469.0,,0.0,434130.0,,25069.0,,,,,,0.0,5506.0,5506.0,,,0.0,434130.0,434130.0,434130.0,0.0,0.0,11189.0,,0.0,596247.0,,,,,,1418299.0,7503229.0,1299986.0,,435000.0,,,,5755129.0,,-4408.0,,-7673496.0,,-7129092.0,,,,,,,,,,,,,0.0,,,,,,7417917.0,-7417917.0,,,,,,,,,,,,,125769.0,,176308.0,,,,871833.0,,547055.0,0.0,4408.0,,,,,,,68204.0,0.0,4530129.0,,,,,0.0,,0.0,,,,0.0,,0.0,,1349821.0,135581.0,0.0,,0.0,,,2593258.0,,150000.0,50000.0,,-88091015.0,0.0,,0.0,,0.0,,0.0,4824659.0,181229.0,,,,,,,,,,179234.0,33.4,,,,,,,,,6084930.0,,,870000.0,,,,,,,,,,,46469.0,,,283142.0,0.0,0.0,79800000.0,,204425.0,,85066566.0,
2012-03-31,2012-05-15,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,1189467.0,,,17546.0,,500932.0,,,,100670462.0,,,0.0,43239.0,0.0,0.0,0.0,,,,11793125.0,9770991.0,,,,,-2739370.0,,0.0,9070522.0,4349243.0,,,,,,,,0.0001,,200000000.0,119617356.0,119617356.0,,11962.0,,,5455.0,,,,,,,,105353.0,,,,,,,,,,,,,,,23880.0,,,,0.0,,0.0,0.0,,,,-0.02,,,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,,,0.0,,,1509761.0,,,15023.0,,,,-2594036.0,,,,,,,,0.0,,439881.0,17546.0,36038.0,150000.0,,12960.0,,0.0,87527.0,,43062.0,,,,,,,1395.0,1395.0,,,,,521657.0,,,0.0,2539.0,,0.0,,,,,,,1795752.0,11793125.0,1690399.0,,435000.0,,,,6591891.0,,0.0,,-2242648.0,,-2594036.0,,,,,,,,,,,,,0.0,,,,,,2674360.0,-2659337.0,,,,,,,,,,,,,,,176308.0,,,,871833.0,,547055.0,0.0,0.0,,,,,,,111266.0,0.0,6441891.0,,,,1875127.0,0.0,,0.0,,,,0.0,,0.0,,,111701.0,,,0.0,,,1164599.0,,50000.0,0.0,,-90685051.0,0.0,,20478.0,,20478.0,,20478.0,1509761.0,43239.0,,,,,,,,,,,,,,,,,,,,9997373.0,,,0.0,,,,,,,,,,,12960.0,,,64157.0,,,,,,,109279152.0,
2012-06-30,2012-08-14,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,638983.0,,,9757.0,377740.0,418446.0,,,,100669068.0,,,,43606.0,,,,,,,9264987.0,7285284.0,,,,,,,,6271500.0,,,,,,,,5665856.0,0.0001,,200000000.0,119617356.0,119617356.0,,11962.0,,,6096.0,,,,,,,,87026.0,,,,,,,,,,,,,,,,,,0.0,0.0,0.0,0.0,0.0,,,,-0.31,,,,,,,,,,,,,,,,,,,,,660682.0,67205.0,134409.0,134409.0,134409.0,134409.0,,1265523.0,,,,,,,,,7078.0,,,,-1875447.0,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,719.0,,,,,,771867.0,,,,2142.0,,,,,,,,,1144455.0,9264987.0,1057429.0,,435000.0,,,,,,,,,,-1875447.0,,-1875447.0,,,,,,,,,,,,,,,,,1883948.0,-1876870.0,,,,,,,,,,,,,40706.0,,176308.0,,,,,,,,,,,0.0,,,,182160.0,,,,,,,,,,,,,,,,,,102872.0,,,,,,424734.0,50000.0,50000.0,0.0,50000.0,-92560498.0,0.0,,13174.0,,13174.0,,,1459214.0,,,,,3229773.0,1.76,,,,,3555000.0,1.67,,,,0.0,,,,,8120532.0,,,,,,,,,,,,,,,,,0.0,0.0,,87000000.0,,,,5980867.0,
2012-09-30,2012-11-14,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,491249.0,,,67621.0,493291.0,736745.0,,,,102726259.0,,,,42151.0,,,,,,,9580455.0,5994068.0,,,,,,,,4472131.0,,,,,,,,5665856.0,0.0001,,200000000.0,129217356.0,129217356.0,,12922.0,,,3640.0,,,,,,,,68698.0,,,,,,,,,,,,,,,,,,0.0,0.0,0.0,0.0,0.0,,,,-0.32,,,,,,,,,,,90722.0,,,,,,,,,203079.0,1067446.0,71907.0,287642.0,287642.0,287642.0,287642.0,2493000.0,2289921.0,,,,,,,539863.0,,1949.0,,,,-1894920.0,,0.0,,,,,,,,,,,,,,,,,,,,,,,,1058000.0,0.0,,,,,,1163966.0,,,,1204.0,,,,,,,,,1296692.0,9580455.0,1227994.0,,435000.0,,,,,,,,,,-1894920.0,,-1894920.0,,,,,,,,,,,,,,,,,1898073.0,-1896124.0,,,,,,,,,,,,,163454.0,,189606.0,,,,,,,,,,,0.0,,,,240350.0,,,,,,,,,,,,,,,,,,131997.0,,,,,,508342.0,50000.0,50000.0,0.0,50000.0,-94455418.0,0.0,,5589.0,,5589.0,,,1389731.0,,,,,3311644.0,1.74,,,,,3505000.0,1.69,,,,0.0,,,,,8283763.0,,,,,,,,,,,,,,,,,0.0,0.0,0.0,89000000.0,,,,5952237.0,
2012-12-31,2013-04-05,10-K,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,374126.0,,328953.0,22320.0,376512.0,376512.0,,1313572.0,,102767193.0,,169746.0,0.0,169746.0,0.0,0.0,38308.0,0.0,,,7808878.0,4288739.0,,852546.0,1658898.0,,,,288151.0,2328074.0,-2393205.0,,,,0.5,,0.0,,0.0001,,200000000.0,6460586.0,6460586.0,,12922.0,,99332.0,54151.0,,,,,-3770936.0,,,50370.0,-646426.0,37139984.0,,,35135946.0,57643.0,,100936.0,881025.0,,20065.0,,37139984.0,435000.0,107823.0,,,,0.0,,0.0,,,,,-1.41,,0.0,-0.34,0.53,,,,-0.058,,,,0.28,,,-64157.0,,,,1727849.0,274990.0,783648.0,287642.0,283792.0,287643.0,287643.0,287642.0,2493000.0,2218010.0,,0.0,0.0,,,,584711.0,,5258.0,,,0.0,-8227114.0,-1.39,-96196.0,-0.02,,,-4417362.0,-4417362.0,2400.0,4417362.0,-181812.0,-182675.0,-244804.0,150000.0,,,,4770.0,-305603.0,,-332465.0,,,,,1198318.0,1019692.0,4042.0,4248.0,,,313700.0,744525.0,682094.0,430825.0,62431.0,-40852.0,6592.0,,0.0,582146.0,,,,,,1443088.0,7808878.0,1392718.0,642080.0,0.0,,70330.0,,6547075.0,,272285.0,,-9212565.0,,-8323310.0,,-8323310.0,146278.0,53958.0,393738.0,,318767.0,210087.0,2544854.0,528854.0,0.0,,0.0,,3.0,,,2.0,8299079.0,-8293821.0,,,,,466715.0,443008.0,,,23707.0,,,,0.0,,175808.0,,50000.0,,871833.0,,67386.0,0.0,15866.0,,,0.0,,,0.0,403705.0,,6396311.0,,0.0,,6396311.0,0.0,,0.0,,,,0.0,,764.0,,1365687.0,52115.0,,,0.0,,,2581094.0,50000.0,50000.0,0.0,50000.0,-96414325.0,0.0,-76000.0,59409.0,,59409.0,,785318.0,5717985.0,169746.0,,,2491169.0,3393522.0,1.72,79686.0,5000.0,,0.0,177750.0,33.4,,0.94,14.8,0.0,3984.0,18.8,,,6365790.0,,,0.0,17900000.0,,,,2016000.0,764.0,,4500000.0,,6396311.0,67943.0,,,64157.0,0.0,0.0,88200000.0,,,,5922717.0,
2013-03-31,2013-05-15,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,667897.0,,194740.0,,445897.0,551778.0,,,,102873653.0,,,0.0,40750.0,0.0,0.0,38308.0,0.0,,,5461646.0,2027559.0,,,,,,,0.0,365023.0,-1963051.0,,,,,,26357874.0,,0.0001,,200000000.0,129562061.0,129562061.0,,12956.0,,,30020.0,,,,,,,,32042.0,,,,,,,,,,,,,,,20594.0,,,,,,0.0,,,,,-0.35,,,,,,,,,,,14536.0,,,,0.0,,,,0.0,346900.0,783648.0,215732.0,283792.0,287643.0,287643.0,287642.0,2493000.0,2146100.0,,0.0,0.0,,,,584711.0,,17380.0,0.0,,0.0,-1975807.0,-0.31,-286548.0,-0.04,,,,,3200.0,,-109964.0,134213.0,-58751.0,50000.0,,,,-1853.0,43592.0,,30750.0,,,,,,981384.0,771.0,910.0,,,727014.0,1220339.0,1091157.0,493325.0,129182.0,39574.0,217.0,,0.0,,,,,,,1251717.0,5461646.0,1219675.0,,435000.0,,,,115744.0,,-4599.0,,-2074196.0,,-2262355.0,,,,,,,,,,,0.0,,0.0,,3.0,,,2.0,1992633.0,-1975253.0,,,,,,,,,,,,,105881.0,,186689.0,,,,871833.0,,42500.0,0.0,4599.0,,,,,,,376639.0,,65743.0,3692000.0,0.0,,65744.0,0.0,,0.0,,,,0.0,,0.0,,,81587.0,,,0.0,,,724876.0,,0.0,,,-98676680.0,0.0,4328.0,47400.0,,47400.0,,599205.0,1267757.0,40750.0,,,5665856.0,3544235.0,1.68,0.0,0.0,,0.0,3555000.0,1.67,0.0,0.0,0.0,,,,,,4209929.0,,,0.0,,,,0.0,,,,,,,18328.0,,,0.0,,,,,,,6377538.0,
2013-06-30,2013-08-14,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,723746.0,,,133905.0,412733.0,492876.0,,,,105033952.0,,,,0.0,,,,,,,5481002.0,2138718.0,,,,,,,,658559.0,,,,,,,1225209.0,,0.0001,,200000000.0,6614149.0,6614149.0,,12956.0,1158462.0,,26980.0,,,,,,,,11700.0,,,,,,,,,,,,,,,,,,,,,0.0,,,,,-0.37,,,,,,,,,,,0.0,,,,,,,,,418810.0,783648.0,143821.0,283792.0,287643.0,287643.0,287642.0,2493000.0,2074188.0,,,,,,,584711.0,,15620.0,,,,-1856351.0,-0.33,-261197.0,-0.04,,,,,,,,,,,,,,,,,,,,,,1131114.0,943076.0,0.0,,,62431.0,317029.0,949805.0,922628.0,632776.0,27177.0,,0.0,,,,,,,,,1228322.0,5481002.0,1216622.0,,435000.0,,,,,,,,,,-2117548.0,,-2350559.0,,,,,,,,,,,,,,,,,1871971.0,-1856351.0,,,,,,,,,,,,,80143.0,,186689.0,,,,,,,,,,,233011.0,,,0.0,423626.0,,,,,,,,,,,,,,,,,,61694.0,,,,,,447337.0,,0.0,,,-100794228.0,0.0,,42600.0,,42600.0,,,1424634.0,,,,283292.0,174041.0,33.8,,,,0.0,177750.0,33.4,,,,,,,,,4252680.0,,,,,,,,,,,,,,,,,0.0,,,,,,,6405802.0,
2013-09-30,2013-11-19,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,802365.0,,,105174.0,315716.0,364547.0,,,,106500753.0,,,,0.0,,,,0.0,,,5129210.0,1846292.0,,,,,,,,585201.0,,,,,,,1121956.0,,0.0001,,200000000.0,7747228.0,7747228.0,,12956.0,2538874.0,,12160.0,,,,,,,,11813.0,,,,,,,,,,,,,,,,,,,,,0.0,,,,,-0.28,,,,,,,,,,,0.0,,,,,,,,,490723.0,783648.0,71909.0,283792.0,287643.0,287643.0,287642.0,2493000.0,2002277.0,,,,,,,584711.0,,7040.0,,0.0,,-1527166.0,-0.25,-241839.0,-0.03,,,,,,,,,,,,,,,,,,,,,,1097511.0,904766.0,0.0,,,62431.0,201553.0,850412.0,823235.0,648859.0,27177.0,,0.0,,,,,,,,,1178725.0,5129210.0,1166912.0,,435000.0,,,,,,,,,,-1769005.0,,-1941866.0,,,,,,,,,,,,,,,,,1534206.0,-1527166.0,,,,,,,,,,,,,48831.0,,195920.0,,,,,,,,,,,172861.0,,,0.0,332682.0,,,,,,,,,,,,,,,,,,65010.0,,,,,,280622.0,,0.0,,,-102563224.0,0.0,,19200.0,,19200.0,,,1253584.0,,,,283292.0,153479.0,32.83,,,,0.0,154156.0,32.75,,,,,,,,,3950485.0,,,,,,,,,,,,,,,,,0.0,,,,,,,6995494.0,
2013-12-31,2014-04-15,10-K,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,990279.0,,,0.0,511098.0,611007.0,,684663.0,,106512828.0,,40750.0,0.0,40750.0,0.0,0.0,123280.0,0.0,,,2786377.0,491520.0,,0.0,0.0,,,,0.0,22489.0,-2305585.0,,,,,,,,0.0001,0.0,200000000.0,8810624.0,8810624.0,,881.0,,44973.0,69160.0,0.0,0.0,,,-1306714.0,,,0.0,-224232.0,39470601.0,,0.0,36837171.0,137611.0,,97326.0,881025.0,,0.0,,39470601.0,435000.0,72357.0,27384.0,,,,,0.0,,,,,-1.33,,0.0,-0.34,0.222,,,,-0.058,,,,,,,0.0,,,1699672.0,0.0,,,,,,,,,,,0.0,0.0,,,,,0.0,40040.0,,0.0,0.0,-6906803.0,-1.04,-2007490.0,-0.29,,0.0,-1530946.0,,3200.0,1530946.0,517490.0,-222110.0,137789.0,50000.0,,,,54847.0,-620698.0,,-90130.0,,,,1100000.0,0.0,,771.0,1438.0,,62482.0,0.0,183398.0,159831.0,183398.0,23567.0,-62482.0,217.0,1699672.0,0.0,435573.0,,,,,,1601286.0,2786377.0,1601286.0,0.0,1699672.0,,,,3742844.0,3742844.0,-23053.0,,6000000.0,-6025376.0,-8914293.0,,-9320165.0,,,,,,,,,1699672.0,,0.0,,,,,1.0,6946289.0,-6906249.0,,,,,354990.0,150458.0,,82936.0,121596.0,,,,99909.0,2294857.0,129989.0,-554.0,,,871833.0,,170000.0,0.0,23053.0,,,405872.0,,,,309200.0,,65743.0,,0.0,,3692844.0,,,0.0,,,,0.0,,0.0,,714859.0,30196.0,,,0.0,,,2037370.0,,,,,-105328618.0,0.0,76000.0,109200.0,,109200.0,,,4908919.0,40750.0,,,,144000.0,31.8,30906.0,0.0,,0.0,144000.0,31.74,0.0,41.7,0.8,0.0,2844.0,14.8,,,1185091.0,,,0.0,,,,0.0,,,0.0,3700000.0,,65743.0,50370.0,,,,0.0,0.0,92500000.0,,,,6995676.0,
2014-03-31,2014-05-15,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,1101098.0,,,,655809.0,739644.0,,,,107464346.0,,,0.0,506165.0,0.0,0.0,0.0,0.0,,,2968494.0,737193.0,,,,,,,0.0,163492.0,141003.0,,,,,,,,0.0001,,200000000.0,9652710.0,9652710.0,,13028.0,,,0.0,,,,,,,,,,,,,,,,,,,,,,435000.0,3556.0,,,,,,0.0,,,,,-0.16,,,,,,,,,,,,,,,0.0,,,,0.0,,,,,,,,,,,0.0,0.0,,,,,,0.0,,,,-1438489.0,-0.16,0.0,0.0,,,,,0.0,,110819.0,0.0,128638.0,0.0,,,,60000.0,0.0,,129670.0,,,,,,,0.0,0.0,,,0.0,183398.0,134831.0,183398.0,48567.0,25000.0,0.0,,0.0,,,,,,,2258226.0,2968494.0,2258226.0,,1699672.0,,,,457500.0,457500.0,0.0,,-316497.0,-316497.0,-1438489.0,,,,,,,,,,,0.0,,0.0,,,,,,1438489.0,-1438489.0,,,,,,,,,,,,,83835.0,,69989.0,,,,871833.0,,42500.0,0.0,0.0,,,,,,,438870.0,,,,0.0,,457500.0,,,0.0,,,,0.0,,0.0,,,26640.0,,,0.0,,,243544.0,,,,,-106767106.0,0.0,0.0,0.0,,0.0,,,1194945.0,506165.0,,,,1601100.0,3.58,,1457100.0,,0.0,1601100.0,3.58,,,0.8,0.0,0.0,0.0,,,710268.0,,,0.0,,,,,,,,457500.0,,,0.0,,,,,,,,,,9037771.0,
2014-06-30,2014-08-12,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,1061234.0,,,,589599.0,667435.0,,,,109137731.0,,,,1118.0,,,,,,,3405777.0,1177955.0,,,,,,,,719224.0,,,,,,,,,0.0001,300000.0,200000000.0,12185988.0,12185988.0,,13260.0,1949381.0,,0.0,,,,,,,,,,,,,,,,,,,,,,435000.0,,,,,,,,,,,,-0.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,-984925.0,-0.09,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,28600.0,,,-50000.0,0.0,183398.0,109830.0,183398.0,73567.0,,0.0,,,,,,,,,2306817.0,3405777.0,2306817.0,,1699672.0,,,,,,,,,,-984925.0,,-984925.0,,,,,,,,,,,,,,,,,956325.0,-956325.0,,,,,,,,,,,,,77836.0,,69989.0,,,,,,,,,,,0.0,,,,348901.0,,,,,,,,,,,,,,,,,,23161.0,,,,,,138608.0,,,,,-107752031.0,,,0.0,,0.0,,,817717.0,,,,,1561600.0,2.84,,,,0.0,1561600.0,2.84,,,,0.0,,,,,1098960.0,,,,,,,,,,,,,,,,,,,,,,,,10857610.0,
2014-09-30,2014-11-19,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,1067744.0,,,,528017.0,599353.0,,,,109150921.0,,,,1161.0,,,,0.0,,,1977704.0,453362.0,,,,,,,,71643.0,,,,,,,,,0.0001,300000.0,200000000.0,12308988.0,12308988.0,,1231.0,1826380.0,,0.0,,,,,,,,,,,,,,,,,,,,,,435000.0,,,,,,,,,,652289.0,,-0.12,,,,,,,,,,576.0,,,,,,,,999672.0,,,,,,,,,,,,,,,,,,,0.0,,700000.0,,-1441802.0,-0.12,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,28600.0,,,-75000.0,0.0,183398.0,84831.0,183398.0,98567.0,,0.0,999672.0,,,,,,,,2319386.0,1977704.0,2319386.0,,999672.0,,,,,,,,,,-1441802.0,,-1441802.0,,,,,,,,,,,,,,,,,713202.0,-713202.0,,,,,,,,,,,,,71336.0,,69989.0,,,,,,,,,,,0.0,,,,296888.0,,,,,,,,,,,,,,,,,,19681.0,,,,,,126788.0,,,,,-109193834.0,,,0.0,,0.0,,,586414.0,,,,,1561100.0,2.84,,,,0.0,1561100.0,2.84,,,,0.0,,,,,-341682.0,,,,,,,,,,,,,,,,,,,,,,,,12261971.0,
2014-12-31,2015-05-22,10-K,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,1204302.0,,,,465512.0,535251.0,,698445.0,,109150983.0,,508628.0,,508628.0,,,,0.0,,,746093.0,419690.0,,,,,,,,216733.0,194244.0,,,,,,,,0.0001,,200000000.0,12775044.0,12775044.0,,1278.0,,13782.0,,0.0,0.0,,,-6333053.0,,,,-2739746.0,48543400.0,,0.0,41512011.0,248933.0,,47356.0,1082211.0,,,730830.0,48543400.0,,13782.0,27384.0,,,,,,,688433.0,688433.0,,-0.5,,0.0,0.34,-0.486,,,,0.146,,,,,,,,0.14,,,,,,,,,,,,,,,,,,,,,,,1834672.0,0.0,-5505536.0,-0.5,,0.0,,0.0,-9072799.0,,3200.0,9072799.0,214023.0,,-75756.0,,,,,120000.0,,,-106243.0,,,,1100000.0,,,94576.0,0.0,,-159831.0,0.0,467761.0,0.0,467761.0,467761.0,159831.0,,,,149371.0,,,,,,2427986.0,746093.0,2427986.0,,300000.0,,,,,2818357.0,,,2500000.0,-2624113.0,-5505536.0,,-5505536.0,,,,,,,,,,,,,,,,,3576288.0,-3576288.0,,,,,204532.0,121596.0,,,82936.0,,,,69739.0,326403.0,9989.0,-1929248.0,,,,,170000.0,,,,,,,,,202957.0,,,,,,2129924.0,,,526500.0,688433.0,,,,,,,714859.0,16414.0,,,,,,640425.0,,,,,-110834154.0,0.0,,,,,,,2935863.0,508628.0,0.0,0.0,,1912906.0,2.44,,1812906.0,,0.0,1914906.0,2.44,0.0,,0.8,0.0,42000.0,32.02,,0.0,-1681893.0,-1681893.0,,,,,,0.0,,,,,,2129924.0,,,,,0.0,,,,,,11121871.0,
2015-03-31,2015-06-18,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,1349826.0,,,,535992.0,668231.0,,,,109268430.0,,,,117447.0,,,,0.0,,,550470.0,227154.0,,,,,,,,8866.0,-207867.0,,,,,,,,0.0001,,200000000.0,12775044.0,12775044.0,,1278.0,1826381.0,,,,,,,,,,,,,,,,,,,,,,,,,3087.0,,,,,,,,,706284.0,,-0.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,,,145524.0,,132980.0,,,,,,,,15331.0,,,,,,,1168.0,1168.0,,,,,,,,,,,,,,,,,,2724341.0,550470.0,2724341.0,,300000.0,,,,,17851.0,,,,-225718.0,-609425.0,,,,,,,,,,,,,,,,,,,608257.0,-608257.0,,,,,,,,,,,,,69739.0,,9989.0,,,,,,,,,,,,,,,218288.0,,,,,,,,,,17851.0,,,,,,,,13327.0,,,,,,78562.0,,,,,-111443579.0,,,,,,,,529695.0,117447.0,,,,3032656.0,1.74,5750.0,1135000.0,,0.0,3044156.0,1.73,0.0,14.8,0.6,0.0,0.0,0.0,,,-2173871.0,,,,,,,0.0,,,,,,,,,,,,,,,,,12737875.0,
2015-06-30,2016-08-29,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,1517545.0,,,,548788.0,809327.0,,,,109408818.0,,,,140388.0,,,,0.0,,,169983.0,148860.0,,,,,,,,113210.0,,,,,,,,,0.0001,,200000000.0,12775044.0,12775044.0,600000.0,1278.0,1826317.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,716197.0,,,-0.11,,,,,,,,,,,,,0.25,,,,,,,,,,,,,,,,,,,,,,,,,,300000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1216.0,,,,,,,,,,,,,,,,,,,3043069.0,169983.0,3043069.0,,,,,,,,,,,,-1439604.0,,,,,,,,,,,,,,,,,,,1438388.0,-1438388.0,,,,,,,,,,,,,135539.0,,9989.0,,,,,,,,,,,,,,,35650.0,,,,,,,,,,,,,,,,,,11134.0,,,,,,299526.0,,,,,-112883182.0,,,,,,,,838862.0,,,,,3373406.0,1.62,,,,0.0,4454995.0,1.53,,,,0.0,,,,,-2873086.0,,,,,,,,,,,,,,,,,,,,,,,,12775044.0,
2015-09-30,2016-10-27,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,1621284.0,,,,634677.0,967916.0,,,,110739887.0,,,,703384.0,,,,0.0,,,46783.0,38045.0,,,,,,,,18217.0,,,,,,,,,0.0001,,200000000.0,12975044.0,12975044.0,600000.0,1298.0,3718804.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,819251.0,,,-0.14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2106.0,,,,,,,,,,,,,,,,,,,3408451.0,46783.0,3408451.0,,,,,,,,,,,,-1191966.0,,-1819671.0,,,,,,,,,,,,,,,,,1189860.0,-1189860.0,,,,,,,,,,,,,145739.0,,,,,,,,,,,,,627705.0,,,,19828.0,,,,,,,,,,,,,,,,,,8738.0,,,,,,108671.0,,,,,-114702853.0,,,,,,,,1081189.0,,,,,7093841.0,1.04,,,,0.0,7353848.0,1.02,,,,0.0,,,,,-3361668.0,,,,,,,,,,,,,,,,,,,,,,,,12902549.0,
2015-12-31,2016-12-29,10-K,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,1790648.0,,,,789852.0,1094852.0,,708334.0,,110136056.0,,985114.0,,985114.0,,,,0.0,,,37303.0,30778.0,,,,,,,,21547.0,-195186.0,,,250000.0,,,,,0.0001,,200000000.0,13187544.0,13187544.0,600000.0,1319.0,3468804.0,9889.0,,0.0,0.0,,,-1246071.0,,,,-213826.0,50003297.0,,0.0,42315384.0,248933.0,,314633.0,1474625.0,,,850334.0,50003297.0,,9889.0,,,,,,,,946142.0,,,-0.34,,0.0,0.34,-0.337,,,,0.048,,,,,,,,0.14,,,,,,,,,,,,,,,,,,,,,,,500000.0,,,,,,0.0,0.0,-1459897.0,,3200.0,1459897.0,586346.0,,559601.0,,,,,,,,-3715.0,,,,,,,82594.0,7547.0,,,,467761.0,0.0,467761.0,467761.0,,,,,125203.0,,,,,,3831642.0,37303.0,3831642.0,,,,,,,857709.0,,,,-1052895.0,-3697560.0,,-4325265.0,,,,,,,,,,,,,,,,,3114966.0,-3114966.0,,,,,222736.0,93436.0,42000.0,44700.0,42600.0,,,,305000.0,6525.0,,-582594.0,,,,,,,,,627705.0,627705.0,,,,9231.0,,600000.0,,,,600000.0,,,,257709.0,,,,,,-3697560.0,714859.0,6525.0,,,,,,361484.0,,,,,-114531714.0,,,,,,,,2753482.0,985114.0,0.0,0.0,,7078342.0,0.95,52000.0,5534692.0,,1400.0,8054346.0,0.94,,28.76,0.67,,60000.0,0.6,,0.0,-3794339.0,-3794339.0,,,,,,,,,,,,,,,,,0.0,,,,,,12859938.0,
2016-03-31,2017-03-01,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,1761805.0,,,,890678.0,1268578.0,,,,110789291.0,,,,25530.0,,,,0.0,,,131768.0,128506.0,,,,,,,,119275.0,97728.0,,,,,,,,0.0001,,200000000.0,13187544.0,13187544.0,600000.0,1319.0,3468804.0,,,,,,,,,,,,,,,,,,,,,,,,,3263.0,,,,,,,,1046769.0,,,-0.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-28843.0,,173726.0,,,,,,,,,,,,,,,2573.0,2573.0,,,,,,,,,,,,,,,,,,4077152.0,131768.0,4077152.0,,,,,,,350627.0,,,,-252899.0,-426575.0,,,,,,,,,,,,,,,,,,,424002.0,-424002.0,,,,,,,,,,,,,377900.0,,,-2573.0,,,,,,,,,,,,250000.0,,9231.0,,,,,250000.0,,,,,100627.0,,100627.0,,,,-426575.0,,3262.0,,,,,,83333.0,,,,,-115585994.0,,,,,,,,340669.0,25530.0,,,,7034091.0,0.75,45000.0,,,0.0,7442598.0,0.74,,32.67,,0.0,,,,,-3945384.0,,,,,,,,,,,,,,,,,,,,,,,,13187544.0,
2016-06-30,2017-03-06,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,1890612.0,,,,997152.0,1583552.0,,,,110798217.0,,,,8932.0,,,,0.0,,,24610.0,12845.0,,,,,,,,12845.0,,,,,,,,,0.0001,,200000000.0,13242544.0,13242544.0,600000.0,1325.0,3413804.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1070119.0,,,-0.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2893.0,,,,,,,,,,,,,,,,,,,4574283.0,24610.0,4574283.0,,,,,,,,,,,,-613220.0,,,,,,,,,,,,,,30000.0,,,,,610327.0,-610327.0,,,,,,,,,,,,,586400.0,,,,,,,,,,,,,,2750000.0,3000000.0,,,,,,,,,,,,,,,,,,,,,,23350.0,,,,78863.0,,,,,-116199215.0,,,,,,,,531464.0,,,,,7284845.0,0.74,,,,0.0,7292598.0,0.74,,,,,,,,,-4549673.0,,,,,,,,,,,,,,,,,,,,,,,,13191725.0,
2016-09-30,2017-03-21,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,1520982.0,,,,1086885.0,1708385.0,,,,113654316.0,,,,483892.0,,,,0.0,,,1954099.0,1793350.0,,,,,,,,1793350.0,,,,,,,,,0.0001,,200000000.0,13523544.0,13523544.0,600000.0,1353.0,5354574.0,,,,,,,,,,,,,,,,,,,,,,,,16294.0,,,,,,,,,1063865.0,,,-0.14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7413.0,,,,,,,,,,,,,,,,,,,4293232.0,1954099.0,4293232.0,,,,,,,,,,,,-1023352.0,,-1806231.0,,,,,,,,,,,,,,,,,1015939.0,-1015939.0,,,,,,,,,,,,,621500.0,,,,,,,,,,,,,782879.0,,,,,,,,,,,,,,,,,,,,,,144455.0,,,,,6254.0,128698.0,,,,,-116594862.0,,,,,,,,887241.0,,,,,12109330.0,0.73,,,,0.0,12116334.0,0.73,,,,,,,,,-2339133.0,,,,,,,,,,,,,,,,,,,,,,,,13312777.0,
2016-12-31,2017-07-28,10-K,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,1672932.0,,,,982482.0,1670340.0,,13501.0,,113710631.0,,518479.0,,518479.0,,,,0.0,,,1110817.0,940823.0,,,,,,,,930397.0,908850.0,930397.0,,250000.0,,,,,0.0001,,200000000.0,13723544.0,13723544.0,600000.0,1373.0,5154674.0,20026.0,,0.0,0.0,,,-1069610.0,,,6887.0,763945.0,50308962.0,,0.0,42436541.0,438039.0,,391365.0,1681158.0,,,730831.0,50308962.0,,20026.0,,,,,,,,1050327.0,,,-0.28,,0.0,0.34,-0.101,,,,0.058,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,-305665.0,,,305665.0,-117716.0,,575488.0,,6887.0,,,-11767.0,,,1195.0,,,,,,,172825.0,21069.0,,,,467761.0,0.0,467761.0,467761.0,,,,,80166.0,,,,,,4400486.0,1110817.0,4393599.0,,,,,-151731.0,,3104185.0,,-171728.0,,-2023607.0,-2918228.0,-95581.0,-3701107.0,,,,,,,,,,,,,,,,,2840984.0,-2840984.0,,,,,129020.0,42790.0,,41997.0,44233.0,,,,687858.0,169994.0,11767.0,-172825.0,,,,,,,171728.0,,782879.0,782879.0,,,,10426.0,,,,,3000000.0,3000000.0,,,,104185.0,,,,,,-3013809.0,171728.0,158227.0,,,,,,641572.0,,,,,-117449942.0,,,,,,,,2199412.0,518479.0,0.0,0.0,,,,,,,0.0,12116334.0,0.62,,,,,,,,0.0,-3137938.0,-3289669.0,,,,,,,,,,,,3000000.0,,,,,0.0,,,,,,13333143.0,
2017-03-31,2017-07-28,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,1605532.0,,,,1000399.0,1658610.0,,,,113710577.0,,,,,,,,0.0,,,373928.0,215571.0,,,,,,,,176367.0,-754030.0,,,,,,,,0.0001,,200000000.0,14273544.0,14273544.0,600000.0,1427.0,4604674.0,,,,,,,,,,6887.0,,,,,,,,,,,,,,,13502.0,,,,,,,,1047851.0,,-0.05,-0.04,-0.05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-67400.0,,-11730.0,,,,,,,,28778.0,,,,,,,,1957.0,,,,,,,,,,,,,,,,,,4318879.0,373928.0,4311992.0,,,,,-226890.0,,-2476.0,,-1865.0,,-749689.0,-580123.0,-75159.0,,,,,,,,,,,-1956.0,,,,,,,651980.0,-653327.0,,,,,,,,,,,,,658211.0,,11766.0,-3303.0,,,,,,,1865.0,,,,,,,39204.0,,,,,,,,,,,,-2476.0,,,,-655283.0,,146591.0,,0.0,,,2476.0,130762.0,,,,,-118030066.0,,,,,,,,522565.0,,,,,12110469.0,0.73,,,,0.0,12116334.0,0.73,,,,,,,,,-3718062.0,-3944952.0,,,,,,,,,,,,,,,,,,,,,,,14045264.0,
2019-12-31,2021-04-23,10-K,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,967126.0,,,,,2796689.0,,200965.0,114020581.0,,,,,,,,,,,,35435.0,32795.0,2640.0,,,,,400.0,,400.0,,400.0,-81715.0,250000.0,,,,,0.0001,,200000000.0,14489399.0,14489399.0,600000.0,1449.0,,,,,,1660000.0,0.15,151422.0,,,,44271.0,34513400.0,,,28067400.0,216800.0,3451000.0,,1165300.0,830200.0,,513400.0,34513400.0,,58175.0,,,,,,,,725425.0,,0.15000000000000002,0.05,0.15000000000000002,0.0,0.21,-0.226,0.0,-0.021,0.0,0.063,0.026,,,,,,,,,,,,,,,,,,,,,,,,1659917.0,,,,,,,,,,,,,,,,,-195693.0,77511.0,,-631636.0,,,,-12541.0,,,,25971.0,,,,,,,43787.0,,8716.0,,,,,,,,,,,3500.0,239600.0,74730.0,83642.0,81228.0,,4885198.0,35435.0,4762989.0,,,122209.0,,-559503.0,55447.0,,,,-137162.0,,2316755.0,-87547.0,,,,,,,,,,,3227860.0,,273749.0,,,,,837002.0,-1014708.0,,,,,,,,,,57505.0,,,138972.0,,0.0,,,3800.0,,,,,,,,,,,,32395.0,,,,,,,,,,,155209.0,-99762.0,,,,2213152.0,203605.0,2640.0,,,,,99762.0,301729.0,,,,,-118912290.0,,,,,,,,712979.0,,,,,12111333.0,0.62,,,,,12111333.0,0.62,,,,,,,,,-4290260.0,-4849763.0,,,,,,,,,,,,,,,,,,,,,,,14485604.0,
2020-03-31,2021-09-03,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,1040045.0,,,,,2890440.0,,201386.0,114020581.0,,,,,,,,,,,,129674.0,114914.0,,,,,,,,2926.0,,2926.0,2526.0,250000.0,,,,,0.0001,,200000000.0,14489399.0,14489399.0,600000.0,1449.0,,,,,,66000.0,,,,,,,,,,,,,,,,,,,,421.0,,421.0,,,,,,690050.0,,,-0.01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,72920.0,,93751.0,,,,-12541.0,,,,79594.0,,,,,,,15931.0,,4173.0,,,,,,,,,,,,,,,,,5148251.0,129674.0,4902511.0,,,245740.0,,-578554.0,96383.0,,,,-93857.0,,-149763.0,-19051.0,,,,,,,,,,,,,281976.0,,,,,152883.0,-152883.0,,,,,,,,,,,,,128973.0,,12541.0,,,,,,,,,,,,,,,111988.0,,,,,,,,131758.0,,,,-35375.0,,,,-168814.0,203605.0,2219.0,,,,,35375.0,46605.0,,,,,-119062053.0,,,,,,,,106278.0,,,,,14811333.0,0.62,,,,0.0,14811333.0,0.62,,,,0.0,,,,,-4440023.0,-5018577.0,,,,,,,,,,,,,,,,,,,,,,,14489399.0,
2020-06-30,2021-09-17,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,821673.0,,,,,2981766.0,,201756.0,115553469.0,,,,,,,,,,,,1341837.0,1332895.0,,,,,,,,1312473.0,,1312473.0,,250000.0,,,,,0.0001,,200000000.0,16701788.0,16701788.0,,1670.0,,,,,,68000.0,,,,,,,,,,,,,,,,,,,,,,370.0,,,,,,650900.0,,0.03,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,600000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15917.0,,,,,,,,,,,,,,,,,,,5019128.0,1341837.0,4744543.0,,,274585.0,,-606165.0,,,,,,,435787.0,-27611.0,,,,,,,,,,,,,290204.0,,,,,242658.0,357342.0,,,,,,,,,,,,,200486.0,,7093.0,50834.0,,,,,,,,,,,,,,20422.0,,,,,,,,,,,,,,,,408176.0,203605.0,1849.0,,,,,,49121.0,,,,,-118626265.0,,,,,,,,193538.0,,,,,14811333.0,0.62,,,,,14811333.0,0.62,,,,,,,,,-3071126.0,-3677291.0,,,,,,,,,,,,,,,,,,,,,,102352867.0,,15024262.0
2020-09-30,2021-10-27,10-Q,"Gene Biotherapeutics, Inc.",CRXM,CIK0000772320,USD,661950.0,,,,,3055405.0,2986717.0,202126.0,115551857.0,,,,,,,,,,,,974817.0,800745.0,,,,,,,,781571.0,,781571.0,,250000.0,,,,,0.0001,,200000000.0,31126575.0,31126575.0,,3112.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,370.0,,,,,,590900.0,,,-0.015,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12706.0,,,,,,,,,,,,,,178073.0,73744.0,21279.0,83050.0,9927.0,5053515.0,974817.0,4926668.0,,,25663.0,,-646438.0,,,,,,,-361132.0,-40273.0,,,,,,,,,,,-12706.0,,551451.0,,,,,388699.0,-388699.0,168146.0,66962.0,101184.0,162090.0,,,,,,,0.0525,,210372.0,,7074.0,,,19414.0,,,,,,,,,,,,19174.0,,,,,,,,,,,,,,,,-401405.0,207034.0,4908.0,,,,,,66116.0,,,,,-118987399.0,,,,,,,,322583.0,,,,,12111333.0,0.62,,,,,,,,,,,,,,,-3432259.0,-4078698.0,,,,,,,,,,,,,,,,,,,,,,,24449004.0,
